Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001410578-25-000673
Filing Date
2025-04-09
Accepted
2025-04-09 17:21:10
Documents
101
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ento-20241231x10ka.htm   iXBRL 10-K/A 2804862
2 EX-4.20 ento-20241231xex4d20.htm EX-4.20 69321
3 EX-31.1 ento-20241231xex31d1.htm EX-31.1 13998
4 EX-31.2 ento-20241231xex31d2.htm EX-31.2 13947
5 EX-32.1 ento-20241231xex32d1.htm EX-32.1 9807
  Complete submission text file 0001410578-25-000673.txt   12008360

Data Files

Seq Description Document Type Size
6 EX-101.SCH ento-20241231.xsd EX-101.SCH 92571
7 EX-101.CAL ento-20241231_cal.xml EX-101.CAL 74200
8 EX-101.DEF ento-20241231_def.xml EX-101.DEF 417751
9 EX-101.LAB ento-20241231_lab.xml EX-101.LAB 808131
10 EX-101.PRE ento-20241231_pre.xml EX-101.PRE 610812
104 EXTRACTED XBRL INSTANCE DOCUMENT ento-20241231x10ka_htm.xml XML 1783362
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37853 | Film No.: 25825959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)